Ibio Inc (IBIO.A)

IBIO.A on American Stock Exchange

1.48USD
23 Oct 2014
Price Change (% chg)

$-0.29 (-16.38%)
Prev Close
$1.77
Open
$1.68
Day's High
$1.74
Day's Low
$1.46
Volume
446,444
Avg. Vol
312,671
52-wk High
$3.48
52-wk Low
$0.24

IBIO.A

Chart for IBIO.A

About

iBio, Inc. (iBio) is a biotechnology company focused on commercializing its technologies, the iBioLaunch platform for vaccines and therapeutic proteins, as well as the iBioModulator platform for vaccine enhancement. Vaccine candidates on its platform are applicable to newly emerging strains of hemagglutinin type 1 and neuraminid... (more)
No analyst recommendations are available for IBIO.A.

Overall

Beta: -0.02
Market Cap (Mil.): $119.40
Shares Outstanding (Mil.): 67.46
Dividend: --
Yield (%): --

Financials

  IBIO.A Industry Sector
P/E (TTM): -- 32.88 33.65
EPS (TTM): -0.06 -- --
ROI: -65.66 18.21 17.48
ROE: -65.66 18.89 18.31
Search Stocks

Competitors

  Price Change
Vical Incorporated (VICL.OQ) $1.18 --
Novavax, Inc. (NVAX.OQ) $4.95 +0.10
Medicago Inc. (MDG.TO) -- --
Novartis AG (NOVN.VX) CHF84.95 +0.30
GlaxoSmithKline plc (GSK.L) 1,401.50p +24.50
CSL Limited (CSL.AX) $74.90 +0.28
AstraZeneca plc (AZN.L) 4,305.00p -11.50
Merck Limited (MERK.NS) Rs838.25 +1.15

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks